TILRAY BRANDS INC

Tilray Brands partners with Leicester Tigers and BrewDog, expanding into sports & entertainment while facing financial challenges—can this alliance revitalize its brand?

Tilray Brands pivots into sports‑entertainment with Shock Top, Breckenridge whiskey and BrewDog rugby deals, redefining cannabis as a lifestyle brand.

Tilray Brands sees execs buy back shares, boosting confidence in its cannabis growth strategy and global market leadership.

Tilray Brands Inc. stock rose 2.2% on Aug 5 after a Strong‑Buy upgrade by TD Securities, with insider buys, record 2026 growth, and analysts targeting $11.00.

Tilray Brands posts Q4 loss but FY2026 revenue hits $915M; 2027 guidance aims for $68‑$75M EBITDA and margin growth.

Tilray Brands pivots from beer to Texas spirits and launches discreet THC pouches, aiming to diversify amid cannabis market volatility and regulatory uncertainty.

Tilray Brands Inc. gears up for July 28 earnings, weighing cannabis volatility, a BrewDog pub event, and a downgraded analyst outlook.

Tilray Brands joins Frankfurt Stock Exchange, boosting European liquidity and investor reach for the cannabis & hemp leader.

Tilray Brands expands medical cannabis for UK veterans, launching a dedicated Lyphe clinic program amid DEA scrutiny—evidence‑based relief for veterans.

Tilray Brands Q3 tops expectations with record revenue, a narrowed loss, and a positive EPS, yet market sentiment remains cautious amid high valuation and ongoing net‑loss pressure.